Suppr超能文献

立体定向磁共振引导在线自适应放疗再放疗(SMART reRT)治疗局部复发性胰腺腺癌:病例报告。

Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.

机构信息

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA; Souther Illinois University, Carbondale, IL, USA.

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.

出版信息

Med Dosim. 2021;46(4):384-388. doi: 10.1016/j.meddos.2021.04.006. Epub 2021 Jun 11.

Abstract

INTRODUCTION

Stereotactic MR-guided online adaptive radiation therapy (SMART) has demonstrated a superior radiotherapeutic ratio for pancreatic patients, by enabling dose escalation while minimizing the dose to the proximal gastrointestinal organs at risk through online adaptive radiotherapy. The safe delivery of stereotactic body radiation therapy (SBRT) is of particular importance in the reirradiation setting and has been historically limited to CT-based nonadaptive modalities. Herein, we report the first use of online adaptive radiotherapy in the reirradiation setting, specifically for treatment of locally recurrent pancreatic adenocarcinoma through SMART reirradiation (SMART reRT).

CASE DESCRIPTION

We describe the treatment of a 68-year-old male who was diagnosed with, unresectable locally advanced pancreatic adenocarcinoma. Initial treatment included FOLFIRINOX followed by 45 Gy in 25 fractions on a helical intensity-modulated radiotherapy (IMRT) device with concurrent capecitabine, followed by a boost of 14.4 Gy in 8 fractions to a on an MR-guided radiotherapy (MRgRT) linac. At approximately 12 months from initial radiotherapy, the patient experienced local progression of the pancreas body/tail and therefore SMART reRT of 50 Gy in 5 fractions was initiated. The technical considerations of cumulative dose for gastrointestinal organs across multiple courses, treatment planning principles, and adaptive radiotherapy details are outlined in this case study. The patient tolerated treatment well with minimal fatigue.

CONCLUSIONS

The therapeutic ratio of reirradiation may be improved using daily MR guidance with online adaptive replanning, especially for lesions in proximity to critical structures. Future studies are warranted to assess long-term outcomes of dose escalated MR-guided reRT, define OAR dose constraints for reRT, and assess cumulative dose across the adapted SMART reRT fractions and the original RT plan.

摘要

简介

立体定向磁共振引导在线自适应放射治疗(SMART)通过在线自适应放疗,在提高剂量的同时,最大限度地减少了危及近端胃肠道器官的剂量,为胰腺患者提供了更好的放射治疗效果。在再放疗环境中,立体定向体部放射治疗(SBRT)的安全实施尤为重要,历史上仅限于基于 CT 的非自适应模式。在此,我们报告了在线自适应放疗在再放疗环境中的首次应用,特别是通过 SMART 再放疗(SMART reRT)治疗局部复发性胰腺腺癌。

病例描述

我们描述了一位 68 岁男性的治疗情况,他被诊断为无法切除的局部晚期胰腺腺癌。初始治疗包括 FOLFIRINOX,然后在螺旋调强放疗(IMRT)设备上进行 25 次分割,每次 45 Gy,并同时给予卡培他滨,然后在 MR 引导放疗(MRgRT)直线加速器上进行 8 次分割,每次 14.4 Gy 的增量照射。在初始放疗后约 12 个月,患者出现胰腺体/尾部局部进展,因此开始进行 50 Gy 的 5 次分割 SMART reRT。本病例研究概述了多次治疗过程中胃肠道器官累积剂量的技术考虑因素、治疗计划原则和自适应放疗细节。患者耐受治疗,仅出现轻微疲劳。

结论

使用每日 MR 引导和在线自适应重新规划可能会提高再放疗的治疗比,特别是对于靠近关键结构的病变。需要进一步研究来评估剂量递增的 MR 引导再放疗的长期结果,为再放疗定义 OAR 剂量限制,并评估适应 SMART reRT 分数和原始 RT 计划的累积剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验